AAAAAA

   
Results: 1-16 |
Results: 16
Recombinant human IGF-I does not modify the ACTH and cortisol responses tohCRH and hexarelin, a peptidyl GH secretagogue, in humans
Authors: Gianotti, L Ramunni, J Lanfranco, F Maccagno, B Giordano, R Broglio, F Maccario, M Muller, EE Ghigo, E Arvat, E
Citation: L. Gianotti et al., Recombinant human IGF-I does not modify the ACTH and cortisol responses tohCRH and hexarelin, a peptidyl GH secretagogue, in humans, J ENDOC INV, 24(2), 2001, pp. 67-71
Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, onsomatotroph and corticotroph secretion in humans
Authors: Arvat, E Maccagno, B Ramunni, J Giordano, R Broglio, F Gianotti, L Maccario, M Camanni, F Ghigo, E
Citation: E. Arvat et al., Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, onsomatotroph and corticotroph secretion in humans, EUR J ENDOC, 143(5), 2000, pp. 601-606
Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans
Authors: Arvat, E Maccagno, B Ramunni, J Maccario, M Giordano, R Broglio, F Camanni, F Ghigo, E
Citation: E. Arvat et al., Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans, EUR J ENDOC, 143(1), 2000, pp. 99-104
Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients
Authors: Grottoli, S Arvat, E Gauna, C Maccagno, B Ramunni, J Giordano, R Maccario, M Deghenghi, R Ghigo, E
Citation: S. Grottoli et al., Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients, INT J OBES, 24, 2000, pp. S136-S137
Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa
Authors: Gianotti, L Fassino, S Daga, GA Lanfranco, F De Bacco, C Ramunni, J Arvat, E Maccario, M Ghigo, E
Citation: L. Gianotti et al., Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa, CLIN ENDOCR, 52(6), 2000, pp. 713-720
Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans
Authors: Gianotti, L Maccario, M Lanfranco, F Ramunni, J Di Vito, L Grottoli, S Muller, EE Ghigo, E Arvat, E
Citation: L. Gianotti et al., Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans, J CLIN END, 85(10), 2000, pp. 3604-3608
Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels
Authors: Mazza, E Maccario, M Ramunni, J Gauna, C Bertagna, A Barberis, AM Patroncini, S Messina, M Ghigo, E
Citation: E. Mazza et al., Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels, J ENDOC INV, 22(9), 1999, pp. 681-687
Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease
Authors: Arvat, E Ramunni, J Giordano, R Maccagno, B Broglio, F Benso, A Deghenghi, R Ghigo, E
Citation: E. Arvat et al., Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease, J ENDOC INV, 22(1), 1999, pp. 23-28
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients
Authors: Maccario, M Ramunni, J Oleandri, SE Procopio, M Grottoli, S Rossetto, R Savio, P Aimaretti, G Camanni, F Ghigo, E
Citation: M. Maccario et al., Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients, INT J OBES, 23(6), 1999, pp. 612-618
Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women
Authors: Maccario, M Mazza, E Ramunni, J Oleandri, SE Savio, P Grottoli, S Rossetto, R Procopio, M Gauna, C Ghigo, E
Citation: M. Maccario et al., Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women, CLIN ENDOCR, 50(5), 1999, pp. 595-600
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease
Authors: Arvat, E Ramunni, J Maccagno, B Giordano, R Broglio, F Deghenghi, R Boscaro, M Ghigo, E
Citation: E. Arvat et al., Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease, NEUROENDOCR, 70(3), 1999, pp. 200-206
The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans
Authors: Arvat, E MacCagno, B Ramunni, J Di Vito, L Giordano, R Gianotti, L Broglio, F Camanni, F Ghigo, E
Citation: E. Arvat et al., The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans, J CLIN END, 84(8), 1999, pp. 2611-2615
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans
Authors: Ghigo, E Gianotti, L Arvat, E Ramunni, J Valetto, MR Broglio, F Rolla, M Cavagnini, F Muller, EE
Citation: E. Ghigo et al., Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans, J CLIN END, 84(1), 1999, pp. 285-290
Influence of galanin and serotonin on the endocrine response to Hexarelin,a synthetic peptidyl GH-secretagogue, in normal women
Authors: Arvat, E Maccagno, B Ramunni, J Broglio, F Lanfranco, F Giordano, R Benso, A Deghenghi, R Ghigo, E
Citation: E. Arvat et al., Influence of galanin and serotonin on the endocrine response to Hexarelin,a synthetic peptidyl GH-secretagogue, in normal women, J ENDOC INV, 21(10), 1998, pp. 673-679
The IGF-I response to very low rhGH doses is preserved in human ageing
Authors: Arvat, E Ceda, G Ramunni, J Lanfranco, F Aimaretti, G Gianotti, L Broglio, F Ghigo, E
Citation: E. Arvat et al., The IGF-I response to very low rhGH doses is preserved in human ageing, CLIN ENDOCR, 49(6), 1998, pp. 757-763
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma
Authors: Arvat, E Giordano, R Ramunni, J Arnaldi, G Colao, A Deghenghi, R Lombardi, G Mantero, F Camanni, F Ghigo, E
Citation: E. Arvat et al., Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma, J CLIN END, 83(12), 1998, pp. 4207-4211
Risultati: 1-16 |